Long-term follow-up after tight control of blood pressure in type 2 diabetes

Cited by (761)

Items 601–700 of 761

1. Prise en charge de la maladie rénale diabétique
   2019 · Elsevier eBooks
2. Less Timely Initiation of Glucose-Lowering Medication Among Younger and Male Patients With Diabetes and Similar Initiation of Blood Pressure-Lowering Medication Across Age and Sex: Trends Between 2015 and 2020
   Martina Ambrož, Sieta T. de Vries, Klaas Hoogenberg, Petra Denig · 2022 · Frontiers in Pharmacology
3. Treatment of cardiovascular risk factors in type 2 diabetes : time trends and clinical practice
   Eva Fhärm · 2010 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
4. Progressive elements in type 2 diabetes, studies on secondary failure and diabetic complications
   Lars Kärvestedt · 2008 · Figshare
5. Implications of UKPDS evidence
   Ram Kela, Melanie Jane Davies · 2010 · Practice Nursing
6. Present recommendations in type 2 diabetes treatment
   Harold E. Lebovitz · 2009 · Endocrinología y Nutrición
7. Beta-Blockers and Hypertension
   John Malcolm Cruickshank · 2009 · Journal of the American College of Cardiology
8. DIABETES CONTROL – THE LEGACY OF A MEMORY
   Vijay AP, SP Chan · 2009 · Journal of Health and Translational Medicine
9. Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular American Academy of Family Physicians; American Association of Prevention of Cardiovascular Disease): Developed in Collaboration With the Measures (Writing Committee to Develop Performance Measures for Primary Cardiology Foundation/American Heart Association Task Force on Performance Cardiovascular Disease in Adults: A Report of the American College of ACCF/AHA 2009 Performance Measures for Primary Prevention of
   Samia Mora, Thomas A. Pearson, Martha J. Radford, Gerald W. Smetana, Stephen Havas, Darwin R. Labarthe, Marian C. Limacher, Frederick Redberg, Emelia J. Benjamin, Vera Bittner et al. · 2009
10. Is legacy a myth or a reality? We should know, and we do not
    François Gueyffier, Michel Cucherat · 2015 · Journal of Hypertension
11. Macrovascular disease and diabetes
    N. Tufton, M. Huda · 2015
12. The role of aspirin for the primary prevention of cardiovascular disease in individuals with chronic kidney disease
    Johann Auer, Gudrun Lamm · 2021 · European Journal of Preventive Cardiology
13. Diabetic Nephropathy
    Sally M. Marshall, Allan Flyvbjerg · 2016
14. Cardiovascular Epidemiology and Characterization of Atherosclerotic Disease Risk Factors
    Kevin Carl Maki, Martyn R. Rubin · 2010 · Humana Press eBooks
15. Impact of Diabetes Mellitus and the Metabolic Syndrome on the Female Heart
    Illena Antonetti, Gladys Velarde · 2013 · Springer eBooks
16. Managing Hypertension in Patients with Diabetes
    Arthur L.M., David Siegel · 2011 · InTech eBooks
17. Diabetes und Niere – Update 2009
    Günter Wolf · 2009 · Der Diabetologe
18. 婦人科開腹手術における，高用量レミフェンタニル投与の手術侵襲ストレス抑制作用，術後QOLに与える影響
    田中 典子, 田中 雅輝, 勇登 桑迫 · 2013
19. A normoglykaemia elérésének korlátai inzulinkezelt 2-es típusú cukorbetegekben
    Viktória Ferencz, Beatrix Annamária Domján, László Gerő, Tímea Tänczer, Ádám Gyula Tabák · 2015 · Orvosi Hetilap
20. Relación del índice arteriovenoso de la retina con las lesiones orgánicas subclínicas en pacientes hipertensos y diabéticos
    Javier Parra Sánchez · 2012
21. ACCORD, ADVANCE und VADT – Paradigmenwechsel in der Diabetologie?
    Tobias Lohmann, Matthias Möhlig, Andreas F. H. Pfeiffer · 2009 · Clinical Research in Cardiology Supplements
22. Glycemia and CVD and Its Management
    Jeffrey Wayne Stephens, Akhila Mallipedhi, Stephen Charles Bain · 2014
23. Update Typ-2-Diabetes anhand ausgewählter aktueller Publikationen
    Monika Kellerer · 2009 · Der Diabetologe
24. Hypertension and Cardiovascular Disease and Its Management
    José Antonio García‐Donaire, Luis Miguel Ruilope · 2014
25. The Efficacy of Ganoderma lucidum for Treatment of Cardiovascular Risk Factors
    Nerida L. Klupp · 2012
26. 関節リウマチにおけるTreat-to-targetへの期待と問題点
    藤井 隆夫 · 2012 · 臨床リウマチ
27. Nichtmedikamentöse und medikamentöse Therapie bei arterieller Hypertonie
    Joachim D. Hoyer · 2013 · Der Kardiologe
28. Cerebral blood flow control in small vessel disease
    Yu-Sok Kim · 2014 · UvA-DARE (University of Amsterdam)
29. HTA et bêtabloquants : la controverse
    D. Obréja, Stéphane Laurent · 2010 · Archives des Maladies du Coeur et des Vaisseaux - Pratique
30. La prévention primaire par les statines du risque cardiovasculaire des diabétiques : un mauvais procès en place publique
    André Grimaldi · 2013 · Archives des Maladies du Coeur et des Vaisseaux - Pratique
31. Hypertension in diabetes mellitus
    Paul Kieran Whelton · 2009 · Endocrinología y Nutrición
32. Hypertensiebehandeling bij diabetes type 2
    Meggy van Kruijsdijk · 2013 · TvPO
33. The challenge of stopping the knocking down of metabolic dominos upstream
    Tomohiro Katsuya, Ryuichi Morishita · 2010 · Hypertension Research
34. Nauwkeurige glycaemische en tensiecontrole bij diabetes type 2, effecten op de lange termijn
    P. de Klaver · 2009 · Medisch-Farmaceutische Mededelingen
35. Variations pondérales, risque cardiométabolique et impact des médicaments antidiabétiques chez le diabétique de type 2
    Nicolas Danchin, É. Eschwège, Saïd Bekka, Michel Krempf · 2010 · Annales de Cardiologie et d Angéiologie
36. Pharmacological cardioprotection in diabetes
    Idris Harding, Derek M. Yellon, Robert M Bell · 2015 · Diabetes Management
37. Intérêt d’une prise en charge précoce de l’hypertension artérielle sur le risque cardiovasculaire chez les patients diabétiques
    Ariane Sultan · 2014 · Médecine des Maladies Métaboliques
38. Editorial: Sailing across the sea of guidelines
    A. Vlad · 2013 · Romanian Journal of Diabetes Nutrition and Metabolic Diseases
39. Unfavorable Effects of Intensive Glucose Lowering on Mortality: Lessons from the 5-Year Follow-up of the ACCORD Trial
    Soo Kyung Lim, Martin K. Rutter · 2011 · Current Cardiovascular Risk Reports
40. Complicações macrovasculares do diabetes melito: peculiaridades clínicas, de diagnóstico e manejo Macrovascular diabetic complications: clinical characteristics, diagnosis and management
    Cristina Bergmann Triches, Jorge Luiz Gross, Mirela Jobim de Azevedo · 2009
41. Wat is de eerste keus bij behandeling van hypertensie bij type 2 diabetes?
    J.W.F. Elte · 2010 · Bohn Stafleu van Loghum eBooks
42. Benefits of hypertension management in diabetes: An opportunity not to be missed
    Krzysztof Narkiewicz, Suzanne Oparil, Sverre Erik Kjeldsen, Thomas Hedner · 2008 · Blood Pressure
43. The prevalence and management of hypertension in a population of adults with type 2 diabetes in the Adamawa Region (Cameroon): A retrospective analysis
    Olivier Pancha Mbouemboue · 2012 · International Journal of Medicine and Medical Sciences
44. 8 Hypertensie en circulatiestoornissen
    Johannes J. VAN LIESHOUT, Gert A. van Montfrans, Henk Simon Brand · 2012 · Bohn Stafleu van Loghum eBooks
45. Place des bêtabloquants dans l’HTA
    Bernard Vaisse · 2010 · Archives des Maladies du Coeur et des Vaisseaux - Pratique
46. Update on type 2 diabetes
    Joel Alex Dave, Naomi Sharlene Levitt · 2009
47. Strategies and Goals for Hypertension Control in Patients With Diabetes Mellitus
    Theodore A. Kotchen · 2010 · Hypertension
48. News From Recent Clinical Trials: Implications for Clinical Practice and the Treatment of Hypertension
    Keith C. Ferdinand · 2009 · Journal of Clinical Hypertension
49. Insulin Therapy and Clinical Inertia: the Costs for Patients and health systems
    Jeremy M. Gleeson, Debra Gordon · 2011
50. Update on type 2 diabetes Type 2 diabetes is increasingly common and we need to offer our patients better outcomes.
    Joel Alex Dave, Naomi Sharlene Levitt · 2009
51. Treatment algorithm of high blood pressure in type 2 diabetes Algoritmo de tratamiento de la hipertensión arterial en la diabetes mellitus tipo 2
    P. Pedrianes Martín · 2009
52. Interdisciplinary Council on Quali Blood Pressure Research, Council on Peripheral Vascular Disease, and Cardiovascular Nursing, Council on Epidemiology and Prevention, Council for High and on behalf of the American Heart Association Stroke Council, Council on
    James Frederick Meschia, Wesley S. Moore, Thomas A. Pearson, Robert G. Hart, Judith A. Hinchey, Virginia J. Howard, Edward C. Jauch, Seemant Chaturvedi, Mark A. Creager, Antonio Culebras et al. · 2010
53. Pharmacological treatment of the pathogenetic defects in Type 2 Diabetes. The randomized multi-centre South Danish Diabetes study (SDDS) Short running title: The South Danish Diabetes Study
    Jeppe Gram, Jan Erik Henriksen, Ellen Grodum, Henning Juhl, Tony Bill Hansen, Christian Fynbo Christiansen, Hans Jørgen Gjessing, Henrik M. Hansen, Henning Beck‐Nielsen · 2010
54. Bénéfices à long terme du traitement antihypertenseur et du contrôle strict de la glycémie sur la prévention cardiovasculaire chez les patients diabétiques de type 2 : résultats de l’étude ADVANCE-ON
    Kamel Mohammedi · 2015 · Médecine des Maladies Métaboliques
55. Œdème maculaire diabétique et autres maculopathies du sujet âgé diabétique
    Fanny Varenne, Véronique Pagot-Mathis, Vincent José Soler · 2015 · NPG. Neurologie, psychiatrie, gériatrie/NPG
56. Efficacy and phytochemical screening of selected plants used in management of diabetes mellitus in Machakos, Kenya
    Clare Njoki Kimani · 2013
57. Különböző cardiovascularis kockázatú idős, hypertoniás betegek kezelési elveinek összehasonlítása a magyar és nemzetközi irányelvek alapján (2001–2015)
    Anikó Bödör, István Kiss · 2016 · Orvosi Hetilap
58. Nonsurgical Options for the Treatment of Diabetic Macular Edema
    Constantin Jean Pournaras, Efstratios Mendrinos, Jean-Antoine C. Pournaras · 2012 · ESASO course series
59. “Legacy Effect” of Intensive Control of Type 2 Diabetes
    Allan S. Brett · 2008 · Journal watch
60. 醫療資源耗用、疾病併發症與死亡率在糖尿病人介入組(論質計酬)與比較組之分析--台灣健保資料庫
    陳宇清 · 2014
61. Guía europea sobre prevención de la enfermedad cardiovascular en la práctica clínica (versión 2012) Quinto Grupo de Trabajo de la Sociedad Europea de Cardiología y otras Sociedades sobre la Prevención de la Enfermedad Cardiovascular en la Práctica Clínica (constituido por representantes de nueve sociedades y expertos invitados)
    Joep Perk · 2012
62. Abordagem terapêutica da hipertensão arterial no doente diabético
    Vítor Miguel Fajardo Esteves · 2011 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
63. La maculopathie diabétique du sujet âgé
    Véronique Pagot-Mathis, Vincent José Soler · 2015 · Les cahiers de l année gérontologique
64. 4. Recent Topics of the Mechanism and Treatment of Diabetes Mellitus
    Takashi Kadowaki · 2009 · Nihon Naika Gakkai Zasshi
65. 2) Treatment Strategies for Preventing Atherosclerosis in Patients with Diabetes Mellitus.
    Takashi Kadowaki · 2010 · Nihon Naika Gakkai Zasshi
66. Hypertonie und Diabetes
    R Stöckli, Lukas Zimmerli · 2009 · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
67. Algoritmo de tratamiento de la hipertensión arterial en la diabetes mellitus tipo 2 Treatment algorithm of high blood pressure in type 2 diabetes
    P. Pedrianes Martín · 2009
68. Ghidul european de prevenţie a bolilor cardiovasculare în practica clinică (versiunea 2012) Al Cincilea Comitet al Societăţii Europene de Cardiologie şi a altor Societăţi de Prevenţie a Bolilor Cardiovasculare în Practica Clinică (constituit din reprezentanţi ai nouă societăţi şi experţi invitaţi) Dezvoltat cu contribuţia specială a Asociaţiei Europene pentru Prevenţie şi Reabilitare Cardiovasculară (EACPR)
    Joep Perk · 2014
69. 5. Cardiovascular Diseases
    Hiroto Sone, Nobuhiro Yamada · 2009 · Nihon Naika Gakkai Zasshi
70. Medicinal prevention of pre-diabetes – no purpose?
    Erik Snorre Øfjord, Arne Skag, Steinar Helberg, Dagfinn Aarskog, Knut Risberg, Trine Jacobsen, Samuel Nasrala, Sjur Bakken, Unni Syversen, Trond Geir Jenssen · 2011 · Tidsskrift for Den norske legeforening
71. Effectiveness of Individual-Level Interventions to Prevent Vascular Complications
    Amanda Adler · 2010 · Oxford University Press eBooks
72. Managing the Broad Spectrum of Type 2 Diabetes
    Evelyne Fleury‐Milfort · 2012 · Elsevier eBooks
73. Controle da Pressão Arterial em Pacientes sob Tratamento Anti
    Fernando Dantas Nobre, Artur Beltrame Ribeiro, Décio Mion · 2010
74. Эссенциальная гипертензия у пациентов с сахарным диабетом 2-го типа: актуальные вопросы антигипертензивной терапии в свете медицины, основанной на доказательствах
    Антон Владимирович Барсуков · 2011 · CyberLeninK (CyberLeninka)
75. Od badania ADVANCE do badania ADVANCE-ON — wpływ na rokowanie u pacjentów z nadciśnieniem i cukrzycą typu 2
    Beata Wożakowska−Kapłon, Iwona Gorczyca−Michta · 2015 · Folia Cardiologica
76. Diabetic Maculopathy in the Elderly
    Véronique Pagot-Mathis, Vincent José Soler, Lavoisier Sas · 2015
77. Bioprospecting for hypoglycemic activities and safety of selected traditionally used plants in the management of diabetes mellitus
    Wycliffe Arika Makori · 2016 · Kenyatta University Institutional Repository (Kenyatta University)
78. Integrated Diabetes Care: Coventry and Warwickshire Approach
    Ponnusamy Saravanan, Vinod Patel, Joseph Paul O’Hare, Sudhesh Kumar · 2016 · Springer eBooks
79. Scientific Statement From the American Heart Association Secondary Prevention of Atherosclerotic Cardiovascular Disease in Older Adults: A
    Susan C. Cheng, Dalane W. Kitzman, Mathew S. Maurer, Michael W. Rich, L. Fleg, Daniel E. Forman, Kathy A. Berra, Vera Bittner, James A. Blumenthal · 2014
80. New Concepts for Sympathetic Renal Artery Denervation: Review of Existing Literature and Case Report
    Christian-Hendrik H. Heeger, Lukas Kaiser, Stephanie Brooks, Karl‐Heinz Kück, Martin Bergmann · 2013 · EMJ Interventional Cardiology
81. Langfristige Effekte einer multifaktoriellen Therapie bei Typ-2-Diabetes
    Michael Jecht · 2016 · Der Diabetologe
82. New peroral antidiabetic drugs and heart failure
    Jana Jiráčková, Alena Šmahelová · 2016 · Interní medicína pro praxi
83. Europejskie zalecenia dotyczące leczenia nadciśnienia tętniczego: stanowisko Europejskiego Towarzystwa Nadciśnienia Tętniczego 2009
    Giuseppe Mancia, Stéphane Laurent, Enrico Agabiti‐Rosei, Ettore Ambrosioni, Michel Burnier, Mark J. Caulfield, Renata Cífková, Denis L Clement, António Coca, Anna F. Dominiczak et al. · 2010 · Arterial Hypertension
84. Perspectives on medical treatment of type 2 diabetes mellitus
    Narihito Yoshioka · 2017 · Journal of the Japanese Coronary Association
85. Inkretinanaloga zur Behandlung des Diabetes mellitus Typ 2.
    Georg Kojda · 2010
86. Lower Blood Pressure Goals in High-Risk Cardiovascular Are They Defensible?
    Keith A. Hopkins, George L. Bakris · 2010
87. Diabète sucré ethypertension
    Bernard Bauduceau, L. Bordier · 2017
88. Type 2 diabetes in primary care
    Hermione Clare Price · 2017 · InnovAiT Education and inspiration for general practice
89. Young Asian men with diabetes have the highest risk for acute coronary events: retrospective cohort analyses
    Ansu Basu, Nithya Sukumar, Robert E. J. Ryder · 2018 · JRSM Open
90. Development of Cardiovascular Risk Assessment Model for People with Type 2 Diabetes in Oman
    Abdul Hakeem Alrawahi · 2017 · Griffith Research Online
91. Modern type 2 diabetes treament - practical implications
    Barbora Doležalová · 2018 · Medicína pro praxi
92. L’UKPDS 30 ans après : le livret de caisse d’épargne des diabétologues
    Michel Marre, Florence Travert, Kamel Mohammedi, S. Olivier · 2009 · Médecine des Maladies Métaboliques
93. Results of ADVAVCE study - an advance in the treatment of hypertension and diabetes mellitus
    Karpov IuA · 2008 · Arterial’naya Gipertenziya (Arterial Hypertension)
94. Evaluation of Cardio-Metabolic Effects of Treatment with Incretin-Based Therapies in Patients with Type 2 Diabetes
    Olga Montvida · 2018 · Queensland University of Technology
95. The role of fix-dose combination therapy: from hypertension to dyslipidaemia
    Anna Szyndler, Krzysztof Jerzy Filipiak, Krzysztof Narkiewicz · 2013 · Kardiologia Polska
96. Development of disease progression model in korean patients with type 2 diabetes mellitus
    이동환 · 2013
97. Management of Cardiovascular Risk Factors in Elderly Diabetes Mellitus Patients
    Sung Hoon Yu · 2019 · Journal of Korean Diabetes
98. Use of routinely collected data to assess outcomes in people with diabetes
    Naomi Holman · 2020 · Enlighten: Theses (The University of Glasgow)
99. Désordres cliniques et biologiques associés
    2010 · Elsevier eBooks
100. Désordres cliniques et biologiques associés
     2014 · Elsevier eBooks